BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9215523)

  • 1. Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines.
    Samuel SK; Minish TM; Davie JR
    J Cell Biochem; 1997 Jul; 66(1):9-15. PubMed ID: 9215523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear matrix proteins in normal and breast cancer cells.
    Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
    Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells.
    Spencer VA; Samuel SK; Davie JR
    Cancer Res; 2001 Feb; 61(4):1362-6. PubMed ID: 11245435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of nuclear matrix protein alterations associated with renal cell carcinoma.
    Konety BR; Nangia AK; Nguyen TS; Veitmeier BN; Dhir R; Acierno JS; Becich MJ; Hrebinko RL; Getzenberg RH
    J Urol; 1998 Apr; 159(4):1359-63. PubMed ID: 9507884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer-associated nuclear matrix proteins.
    Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
    Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines.
    Spencer VA; Samuel SK; Davie JR
    Cancer Res; 2000 Jan; 60(2):288-92. PubMed ID: 10667578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of nuclear matrix protein alterations associated with human colon cancer.
    Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
    Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.
    Alberti I; Barboro P; Barbesino M; Sanna P; Pisciotta L; Parodi S; Nicolò G; Boccardo F; Galli S; Patrone E; Balbi C
    J Cell Biochem; 2000 Sep; 79(3):471-85. PubMed ID: 10972984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered nuclear matrix protein profiles in oncogene-transformed mouse fibroblasts exhibiting high metastatic potential.
    Samuel SK; Minish TM; Davie JR
    Cancer Res; 1997 Jan; 57(1):147-51. PubMed ID: 8988056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.
    Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH
    J Cell Biochem; 2002; 86(2):203-12. PubMed ID: 12111990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophoretic analysis of nuclear matrix proteins in human hepatocellular carcinoma.
    Chew EC; Liew CT; Wu S; Yang L; Yam HF; Wang SW; Lee SM; Wang ZH; Chew-Cheng SB
    Anticancer Res; 1997; 17(5A):3581-5. PubMed ID: 9413206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nuclear matrix proteins in the cancer and normal rat prostate.
    Getzenberg RH; Pienta KJ; Huang EY; Coffey DS
    Cancer Res; 1991 Dec; 51(24):6514-20. PubMed ID: 1742724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of nuclear matrix proteins (NMPs) in multiple tissue types with NM-200.4 (an antibody strongly reactive with NMPs found in breast carcinoma).
    Weidner N; Weinberg DS; Hardy SC; Hollister KA; Lidgard GP
    Am J Pathol; 1991 Jun; 138(6):1293-8. PubMed ID: 1711287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells.
    Oesterreich S; Lee AV; Sullivan TM; Samuel SK; Davie JR; Fuqua SA
    J Cell Biochem; 1997 Nov; 67(2):275-86. PubMed ID: 9328833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps.
    Brünagel G; Schoen RE; Getzenberg RH
    J Cell Biochem; 2004 Feb; 91(2):365-74. PubMed ID: 14743395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis.
    Sjakste N; Sjakste T; Vikmanis U
    Exp Oncol; 2004 Sep; 26(3):170-8. PubMed ID: 15494683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear matrix of human ovarian cancer cells in vitro.
    Yang L; Yam GH; Fey EG; Cheng-Chew SB; Tsao GS; Wang ZH; Chew EC
    Anticancer Res; 1998; 18(4A):2535-9. PubMed ID: 9703906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
    Kuo SH; Chen CL; Huang CS; Cheng AL
    Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.